Kezar Life Sciences Company
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
%20.jpg)
Last Funding Type:
Series B
Funding Status:
IPO
Headquarters:
South San Francisco, California, United States
Founded Date:
2015
Investor Type:
N/A
Investment Stage:
N/A
Total Funding:
$78.3M
Technology:
Data-driven Technologies
Employee Number:
11-50
Number Of Exists:
N/A
Estimated Revenue:
$1M to $10M
Investors Number:
10
Industry:
PharmTech